Long-Term Liabilities: The sum of all non-current liabilities.
ProQR Therapeutics N.V. (PRQR) had Long-Term Liabilities of $22.33M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$10.18M |
|
$-10.15M |
|
-- |
|
$10.18M |
|
$20.44M |
|
$-10.26M |
|
$0.14M |
|
$-10.12M |
|
$-10.12M |
|
$-10.15M |
|
$-10.15M |
|
$-10.15M |
|
$-10.15M |
|
$-10.26M |
|
$-9.44M |
|
109.96M |
|
109.96M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$141.42M |
|
$13.86M |
|
$13.86M |
|
$155.28M |
|
$40.55M |
|
-- |
|
|
Long-Term Liabilities |
$22.33M |
$62.87M |
|
$92.41M |
|
$92.41M |
|
$92.41M |
|
143.47M |
|
| Cash Flow Statement Financials | |
$-27.22M |
|
$-0.53M |
|
$56.13M |
|
$107.45M |
|
$136.18M |
|
$28.73M |
|
$3.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.49 |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
100.00% |
|
-100.72% |
|
-100.72% |
|
-- |
|
-99.36% |
|
-99.65% |
|
$-27.75M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
2.24 |
|
40.16 |
|
-10.98% |
|
-10.98% |
|
-6.54% |
|
-10.98% |
|
$0.64 |
|
$-0.25 |
|
$-0.25 |
|